Multidisciplinary care in patients with prostate cancer: Room for improvement

Supportive Care in Cancer

Volumn 21, Issue 8, 2013, Pages 2327-2333

  Strebel, Räto T ^a   Sulser, Tullio ^b   Schmid, Hans Peter ^c   Gillessen, Silke ^a   Fehr, Martin ^d   Huber, Urs ^e   Pless, Miklos ^a   Morant, Rudolf ^f   Winterhalder, Ralph ^a   Cathomas, Richard ^a  

^a Kantonsspital Graubünden ^*  (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Kantonsspital St Gallen Klinik fur Urologie   (Switzerland)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e KLINIK IM PARK   (Switzerland)

^f Tumor Center ZeTuP   (Switzerland)

Author keywords

Disease management; Health care survey; Interdisciplinary communication; Prostate cancer

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER STAGING; HUMAN; INTERDISCIPLINARY COMMUNICATION; ONCOLOGIST; PATIENT CARE; PATIENT REFERRAL; PHYSICIAN; PRIORITY JOURNAL; PRIVATE PRACTICE; PROSTATE CANCER; SWITZERLAND; UROLOGIST;

EID: 84879981516     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1791-x     Document Type: Article

References (28)

1. Picard JC, Golshayan AR, Marshall DT, Opfermann KJ, Keane TE (2012) The multi-disciplinary management of high-risk prostate cancer. Urol Oncol 30:3-15
2. Lu-Yao GL, Albertsen PC, Moore DF et al (2009) Outcomes of localized prostate cancer following conservative management. JAMA 302:1202-1209
3. Cooperberg MR, Broering JM, Carroll PR (2010) Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 28:1117-1123
4. Payne HA, Gillatt DA (2007) Differences and commonalities in the management of locally advanced prostate cancer: results from a survey of oncologists and urologists in the UK. BJU Int 99:545-553
5. Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61-71
6. Mottet N, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59:572-583
7. Cooperberg MR, Cowan J, Broering JM, Carroll PR (2008) High-risk prostate cancer in the United States, 1990-2007. World J Urol 26:211-218
8. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR (2007) Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178:S14-S19
9. Cooperberg MR, Moul JW, Carroll PR (2005) The changing face of prostate cancer. J Clin Oncol 23:8146-8151
10. Jeldres C, Suardi N, Walz J et al (2008) Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. Eur Urol 54:107-116
11. Tannock IF, de Wit R, Berry WR et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502-1512
12. Kantoff PW, Higano CS, Shore ND et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411-422
13. de Bono JS, Oudard S, Ozguroglu M et al (2010) Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 376:1147-1154
14. de Bono JS, Logothetis CJ, Molina A et al (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995-2005
15. Ruhstaller T, Roe H, Thurlimann B, Nicoll JJ (2006) The multidisciplinary meeting: an indispensable aid to communication between different specialities. Eur J Cancer 42:2459-2462
16. Ko C, Chaudhry S (2002) The need for a multidisciplinary approach to cancer care. J Surg Res 105:53
17. Boyle FM, Robinson E, Dunn SM, Heinrich PC (2005) Multidisciplinary care in cancer: the fellowship of the ring. J Clin Oncol 23:916-920
18. Valicenti RK, Gomella LG, El-Gabry EA et al (2000) The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol 18:188-191
19. Gomella LG, Lin J, Hoffman-Censits J et al (2010) Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract 6:e5-e10
20. Valdagni R, Albers P, Bangma C et al (2011) The requirements of a specialist prostate cancer unit: a discussion paper from the European School of Oncology. Eur J Cancer 47:1-7
21. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A (2010) Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28:126-131
22. Soloway MS, Soloway CT, Eldefrawy A, Acosta K, Kava B, Manoharan M (2010) Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 58:831-835
23. Bolla M, de Reijke TM, Van Tienhoven G et al (2009) Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 360:2516-2527
24. Ganswindt U, Stenzl A, Bamberg M, Belka C (2008) Adjuvant radiotherapy for patients with locally advanced prostate cancer - a new standard? Eur Urol 54:528-542
25. Kibel AS (2005) An interdisciplinary approach to treating prostate cancer. Urology 65(6 Suppl):13-18
26. Hamilton AS, Albertsen PC, Johnson TK et al (2011) Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int 107:576-584
27. Cooperberg MR, Broering JM, Litwin MS et al (2004) The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 171:1393-1401
28. Aizer AA, Paly JJ, Zietman AL et al (2012) Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol 30:3071-3076